Literature DB >> 33526804

Prevalence and characteristics of mitral valve prolapse in military young adults in Taiwan of the CHIEF Heart Study.

Pang-Yen Liu1, Kun-Zhe Tsai2, Yen-Po Lin3, Chin-Sheng Lin1, Huan-Chang Zeng2,4, Eiki Takimoto5, Gen-Min Lin6,7,8.   

Abstract

The prevalence of mitral valve prolapse (MVP) among middle- and older-aged individuals is estimated to be 2-4% in Western countries. However, few studies have been conducted among Asian individuals and young adults. This study included a sample of 2442 consecutive military adults aged 18-39 years in Hualien, Taiwan. MVP was defined as displacement of the anterior or posterior leaflet of the mitral valve to the mid portion of the annular hinge point > 2 mm in the parasternal long-axis view of echocardiography. Cardiac chamber size and wall thickness were measured based on the latest criteria of the American Society of Echocardiography. The clinical features of participants with MVP and those without MVP were compared using a two-sample t test, and the cardiac structures were compared using analysis of covariance with adjustment for body surface area (BSA). Eighty-two participants were diagnosed with MVP, and the prevalence was 3.36% in the overall population. Compared with those without MVP, participants with MVP had a lower body mass index (kg/m2) (24.89 ± 3.70 vs. 23.91 ± 3.45, p = 0.02) and higher prevalence of somatic symptoms related to exercise (11.0% vs. 4.9%, p = 0.02) and systolic click in auscultation (18.3% vs. 0.6%, p < 0.01). In addition, participants with MVP had greater left ventricular mass (gm) and smaller right ventricular wall thickness (mm) and dimensions (mm) indexed by BSA than those without MVP (149.12 ± 35.76 vs. 155.38 ± 36.26; 4.66 ± 0.63 vs. 4.40 ± 0.68; 26.57 ± 3.99 vs. 25.41 ± 4.35, respectively, all p-values < 0.01). In conclusion, the prevalence and clinical features of MVP in military young adults in Taiwan were in line with those in Western countries. Whether the novel MVP phenotype found in this study has any pathological meaning needs further investigation.

Entities:  

Year:  2021        PMID: 33526804      PMCID: PMC7851121          DOI: 10.1038/s41598-021-81648-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  43 in total

Review 1.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

2.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

3.  On the frequency of early systolic clicks in mitral valve prolapse.

Authors:  P A Chandraratna
Journal:  Cardiology       Date:  1977       Impact factor: 1.869

4.  Mitral valve prolapse and infective endocarditis.

Authors:  S W MacMahon; J K Roberts; R Kramer-Fox; D M Zucker; R B Roberts; R B Devereux
Journal:  Am Heart J       Date:  1987-05       Impact factor: 4.749

5.  Mitral valve prolapse in the general population. 1. Epidemiologic features: the Framingham Study.

Authors:  D D Savage; R J Garrison; R B Devereux; W P Castelli; S J Anderson; D Levy; P M McNamara; J Stokes; W B Kannel; M Feinleib
Journal:  Am Heart J       Date:  1983-09       Impact factor: 4.749

6.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

7.  Sex-Specific Association Between Serum Uric Acid and Elevated Alanine Aminotransferase in a Military Cohort: The CHIEF Study.

Authors:  Jia-Wei Lin; Kun-Zhe Tsai; Kai-Wen Chen; Fang-Ying Su; Yi-Hwei Li; Yen-Po Lin; Chih-Lu Han; Felicia Lin; Yu-Kai Lin; Chung-Bao Hsieh; Gen-Min Lin
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2019       Impact factor: 2.895

8.  Echocardiographically documented mitral-valve prolapse. Long-term follow-up of 237 patients.

Authors:  R A Nishimura; M D McGoon; C Shub; F A Miller; D M Ilstrup; A J Tajik
Journal:  N Engl J Med       Date:  1985-11-21       Impact factor: 91.245

9.  The Marfan syndrome: cardiovascular physical findings and diagnostic correlates.

Authors:  K Hirata; F Triposkiadis; E Sparks; J Bowen; H Boudoulas; C F Wooley
Journal:  Am Heart J       Date:  1992-03       Impact factor: 4.749

10.  Association between mild anemia and physical fitness in a military male cohort: The CHIEF study.

Authors:  Kun-Zhe Tsai; Shiue-Wei Lai; Chia-Jung Hsieh; Chin-Sheng Lin; Yen-Po Lin; Sung-Chiao Tsai; Pei-Shou Chung; Yu-Kai Lin; Tzu-Chiao Lin; Ching-Liang Ho; Chih-Lu Han; Younghoon Kwon; Chung-Bao Hsieh; Gen-Min Lin
Journal:  Sci Rep       Date:  2019-08-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.